STIM
Neuronetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.90
−2.36%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.08
- Revenue estimate
- $40.4M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.12
- Revenue actual
- $41.6M
- Revenue estimate
- $40.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +15.5%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $5.50
- PT range
- $5.00 – $6.00
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.12 | -$0.05 | Beat 59.35% | $41.6M |
| May 5, 2026 | -$0.17 | -$0.16 | Beat 5.88% | $34.5M |
| Mar 17, 2026 | -$0.11 | -$0.10 | Beat 5.24% | $41.8M |
| Nov 4, 2025 | -$0.12 | -$0.13 | Miss -8.33% | $37.3M |
| Mar 4, 2025 | -$0.26 | -$0.33 | Miss -26.92% | $22.5M |
| Mar 5, 2024 | -$0.26 | -$0.19 | Beat 26.92% | $20.3M |
| Mar 7, 2023 | -$0.43 | -$0.30 | Beat 30.23% | $18.2M |
| Aug 2, 2022 | -$0.43 | -$0.39 | Beat 9.30% | $16.3M |
| May 12, 2022 | -$0.41 | -$0.41 | In line | $14.2M |
| Mar 8, 2022 | -$0.33 | -$0.29 | Beat 12.12% | $15.0M |
| Aug 3, 2021 | -$0.24 | -$0.29 | Miss -20.83% | $14.2M |
| May 4, 2021 | -$0.33 | -$0.31 | Beat 6.06% | $12.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026